MAVS signaling is required for preventing persistent chikungunya heart infection and chronic vascular tissue inflammation.
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
03 08 2023
03 08 2023
Historique:
received:
07
04
2023
accepted:
05
07
2023
medline:
7
8
2023
pubmed:
4
8
2023
entrez:
3
8
2023
Statut:
epublish
Résumé
Chikungunya virus (CHIKV) infection has been associated with severe cardiac manifestations, yet, how CHIKV infection leads to heart disease remains unknown. Here, we leveraged both mouse models and human primary cardiac cells to define the mechanisms of CHIKV heart infection. Using an immunocompetent mouse model of CHIKV infection as well as human primary cardiac cells, we demonstrate that CHIKV directly infects and actively replicates in cardiac fibroblasts. In immunocompetent mice, CHIKV is cleared from cardiac tissue without significant damage through the induction of a local type I interferon response from both infected and non-infected cardiac cells. Using mice deficient in major innate immunity signaling components, we found that signaling through the mitochondrial antiviral-signaling protein (MAVS) is required for viral clearance from the heart. In the absence of MAVS signaling, persistent infection leads to focal myocarditis and vasculitis of the large vessels attached to the base of the heart. Large vessel vasculitis was observed for up to 60 days post infection, suggesting CHIKV can lead to vascular inflammation and potential long-lasting cardiovascular complications. This study provides a model of CHIKV cardiac infection and mechanistic insight into CHIKV-induced heart disease, underscoring the importance of monitoring cardiac function in patients with CHIKV infections.
Identifiants
pubmed: 37537212
doi: 10.1038/s41467-023-40047-w
pii: 10.1038/s41467-023-40047-w
pmc: PMC10400619
doi:
Substances chimiques
MAVS protein, human
0
IPS-1 protein, mouse
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4668Subventions
Organisme : NIAID NIH HHS
ID : R01 AI162774
Pays : United States
Informations de copyright
© 2023. Springer Nature Limited.
Références
Lancet Microbe. 2023 May;4(5):e319-e329
pubmed: 37031687
Trop Med Infect Dis. 2021 Jun 22;6(3):
pubmed: 34206332
Biology (Basel). 2019 May 11;8(2):
pubmed: 31083529
Am J Physiol Heart Circ Physiol. 2019 Aug 1;317(2):H472-H478
pubmed: 31274354
Epidemiol Infect. 2009 Apr;137(4):534-41
pubmed: 18694529
PLoS Pathog. 2011 Oct;7(10):e1002322
pubmed: 22028657
Nat Rev Immunol. 2018 May;18(5):309-324
pubmed: 29379212
Acta Trop. 2023 Jan;237:106705
pubmed: 36183865
Travel Med Infect Dis. 2016 Sep - Oct;14(5):510-512
pubmed: 27345550
PLoS Pathog. 2017 Dec 15;13(12):e1006748
pubmed: 29244871
J Virol. 2014 Aug;88(15):8213-26
pubmed: 24829346
J Exp Med. 2010 Feb 15;207(2):429-42
pubmed: 20123960
Cardiovasc Res. 1998 Aug;39(2):280-300
pubmed: 9798514
Mol Cell Biochem. 2021 Sep;476(9):3241-3252
pubmed: 33881711
MMWR Morb Mortal Wkly Rep. 2023 Jun 09;72(23):636-638
pubmed: 37289652
Antioxid Redox Signal. 2021 Dec;35(16):1376-1392
pubmed: 34348482
Nat Microbiol. 2017 Oct;2(10):1435-1445
pubmed: 28848230
J Immunol. 2016 Dec 1;197(11):4210-4218
pubmed: 27864552
Int J Infect Dis. 2016 Jul;48:78-80
pubmed: 27208636
Cureus. 2017 Jun 27;9(6):e1399
pubmed: 28856072
Clin Infect Dis. 2021 Oct 5;73(7):e2436-e2443
pubmed: 32766829
EMBO Mol Med. 2014 Dec 01;7(1):24-41
pubmed: 25452586
F1000Res. 2017 Mar 29;6:390
pubmed: 28503297
J Immunol. 2012 Apr 1;188(7):2967-71
pubmed: 22371392
J Virol. 2021 Feb 24;95(6):
pubmed: 33361425
Nature. 2014 Jun 12;510(7504):298-302
pubmed: 24805240
J Biol Chem. 2010 Jul 23;285(30):23208-23
pubmed: 20472559
Cardiovasc Res. 2022 Jan 29;118(2):542-555
pubmed: 34647998
Circ J. 2016 Oct 25;80(11):2269-2276
pubmed: 27746422
Cardiovasc Res. 2015 Apr 1;106(1):19-31
pubmed: 25538153
Proc Natl Acad Sci U S A. 2019 Sep 10;116(37):18607-18612
pubmed: 31451661
Cell Rep. 2019 Jul 9;28(2):460-471.e5
pubmed: 31291581
Infect Genet Evol. 2015 Jun;32:401-8
pubmed: 25847693
Viruses. 2020 Jun 28;12(7):
pubmed: 32605312
Cardiovasc Res. 2005 Jan 1;65(1):40-51
pubmed: 15621032
Arq Bras Cardiol. 2019 Sep 23;113(4):783-786
pubmed: 31553384
PLoS Pathog. 2022 May 18;18(5):e1010231
pubmed: 35584192
Cardiovasc J Afr. 2021 Sep-Oct 23;32(5):276-283
pubmed: 34292294
Heart Fail Rev. 2019 Jan;24(1):1-15
pubmed: 29987445
Trends Cardiovasc Med. 2022 Jan;32(1):52-58
pubmed: 33220438
PLoS Pathog. 2017 Feb 16;13(2):e1006155
pubmed: 28207896
Crit Care Med. 2008 Sep;36(9):2536-41
pubmed: 18679124
PLoS Pathog. 2012;8(5):e1002708
pubmed: 22615568
Am J Trop Med Hyg. 2021 Nov 29;106(1):99-104
pubmed: 34844209
J Child Neurol. 2017 Jul;32(8):712-716
pubmed: 28459170
Curr Opin Virol. 2011 Dec;1(6):463-75
pubmed: 22440910
Proc Natl Acad Sci U S A. 2013 Oct 15;110(42):17023-8
pubmed: 24082102
Nature. 2018 Oct;562(7727):367-372
pubmed: 30283141
J Virol. 2011 Jan;85(2):1025-35
pubmed: 21047966
PLoS Negl Trop Dis. 2019 Jan 14;13(1):e0007084
pubmed: 30640900
iScience. 2022 Feb 02;25(3):103865
pubmed: 35243228
J Virol. 2016 Sep 12;90(19):8780-94
pubmed: 27440901
Clin Infect Dis. 2021 Jul 15;73(2):e345-e354
pubmed: 32615591
Nat Rev Immunol. 2013 Jan;13(1):46-57
pubmed: 23237964
Nature. 1983 Jun 23-29;303(5919):701-4
pubmed: 6190091
PLoS One. 2016 Mar 08;11(3):e0151173
pubmed: 26954674
Glob Heart. 2020 Sep 01;15(1):60
pubmed: 32923353